Cervical cancer rates soaring in deprived areas after low vaccine uptake
Analysis from the UK Health Security Agency (UKHSA) underscores this critical public health concern, revealing that insufficient vaccination among children is leaving many women vulnerable to the disease.
The disparity is stark: cervical cancer rates are already 65 per cent higher in England's most deprived areas compared with the least, according to figures from Cancer Research.
HPV refers to a group of common viruses, typically transmitted through sexual contact, which often present no symptoms but can lead to various cancers, including cervical cancer.
Around 13 high-risk types of HPV are known to cause 99.7% of cervical cancers.
The HPV jab is given to boys and girls when they are in Year 8 and is key to wiping out cervical cancer in the UK. Some children receive it in Year 9.
The jab also protects against genital warts and head and neck cancers, such as those in the mouth or throat.
UKHSA data for 2023/24 in England shows inequalities in uptake of the jab in some regions.
By Year 10, HPV coverage in girls was lowest in London (64.9%) and highest in the South East (82.7%).
Among boys, it was also lowest in London (58.9%) and highest in the South East (77.3%).
Meanwhile, at local authority level, Year 10 vaccination levels in girls ranged from 38.7% (Lambeth in London) to 97.6% (Northumberland).
Among boys, it ranged from 28.2% (Lambeth in London) to 92.2% (West Berkshire).
The HPV jab delivers a significantly stronger immune response if given before the age of 16, though getting it when older as part of a catch-up programme still creates a strong response.
Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: "The HPV vaccine, now just a single dose offered in schools, is one of the most powerful tools we have for cancer prevention.
"Every vaccination represents a young person with better protection against the devastating impact of HPV-related cancers, and we must do more to ensure that no teenage girl or boy, young woman or man is denied that protection no matter where they live.
"Although we have seen some increase in the number of young people being vaccinated, uptake is still well below pre-Covid pandemic levels.
"Over a quarter of young people - many thousands - are missing out on this potentially life-saving vaccine.
"We're calling on all parents to return their children's HPV vaccination consent forms promptly.
"This simple action could protect your child from developing cancer in the future."
Dr Ismail said any young adult up to age 25 who missed their school jab can speak to their GP about catch-up options.
He also urged women to still attend cervical screening to ensure they are being checked for changes that could lead to cervical cancer.
In 2023, the then head of NHS England, Amanda Pritchard, said cervical cancer would be wiped out in England by 2040.
Cancer Research UK chief executive Michelle Mitchell said: "Thanks to the power of research and the efforts of NHS staff, a future where almost nobody gets cervical cancer is in sight.
"This progress hinges on people's access to two life-saving offers - HPV vaccination and screening. Together, they give the best protection against the disease.
"Beating cervical cancer means beating it for everyone, so I encourage all parents and guardians to ensure young people don't miss out on getting the HPV vaccine.
"And if you receive your cervical screening invite, don't ignore it."
Dr Amanda Doyle, national director for primary care and community services at NHS England, said: "The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.
"If we can ensure that almost every Year 10 girl in some areas is protected and extremely unlikely to ever develop cervical cancer, we need to match this in every part of the country."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
21 minutes ago
- Scottish Sun
The 10 signs of ‘brain swelling' sloth fever which could be spread by sex after cases spotted in UK for the first time
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) THE UK has reported its first-ever cases of flu-like 'sloth fever'. Three people tested positive for the disease, officially called Oropouche virus, between January and June 2025, new data from the UK Health Security Agency (UKHSA) says. Sign up for Scottish Sun newsletter Sign up 4 Little is known about Oropouche, also called 'sloth fever' Credit: Getty 4 Despite the name, the disease is spread via mosquito Credit: Getty The little-known virus, spread to humans by mosquitoes and biting midges - unlike the name suggests - was also reported in Europe last summer for the first time after it started spreading rapidly in Latin America. Historically, Oropouche was confined to within the Amazon basin in South America, including Brazil, Peru, Argentina, Bolivia, Colombia, and Panama. In 2024, outbreaks also appeared in these regions as well as in Cuba and Barbados, the likely source of some of the 19 cases of sloth fever reported in Europe last year. The first cases of the oropouche in the UK were all linked to travel from Brazil, the UKHSA said. The bug typically circulates between primates, including sloths - hence the nickname - before it is occasionally passed to humans by the critters. Mosquitos and midges found in the UK and wider Europe do not currently spread Oropouche virus disease. Until last year, experts didn't think the virus could spread from person to person. But a study published by Italian scientists in December suggested it could spread in semen, sparking concerns about possible sexual transmission. Scientists are currently investigating whether the infection can be passed on from mothers to babies during pregnancy, after the virus was linked to stillbirths and birth defects. For most people, Oropouche infections are mild, with symptoms typically showing up 4 to 8 days after a bite. I tried the best ways to stop mosquitoes on your summer hols - from sprays, patches & bracelets, one was a dud and stank These can include: Fever Headache Joint pain Muscle aches Chills Nausea and vomiting Rash Sensitivity to light Dizziness Pain behind the eyes UKHSA chiefs have urged anyone who becomes unwell with these symptoms after travel to affected areas. Symptoms typically last less than a week but can occasionally reoccur. In severe cases, the virus can also attack the brain leading to meningitis or encephalitis, which can be fatal. 4 4 It is estimated that fewer than four per cent of patients will develop neurological symptoms. The first ever deaths linked to the virus were reported in Brazil in July 2024, where, sadly, two people died. There are currently no specific antiviral treatments or vaccines available. Treatment for symptoms can include rest, fluids, and the use of medicines to reduce pain and fever.
Sky News
21 minutes ago
- Sky News
Causes, symptoms and how to prevent chikungunya - as cases rise in the UK
Health authorities have warned of a "worrying increase" in cases of a mosquito-borne infection in people returning to the UK from abroad. A total of 73 cases of chikungunya were reported between January and June 2025 - more than double the 27 cases reported in the same period last year, the UK Health Agency (UKHSA) said. Data released by the agency also revealed three cases of oropouche virus, marking the first time the virus has been reported in the UK. Here is everything you need to know about both viruses, from symptoms to prevention and what could be behind the surge in cases. What is chikungunya? Chikungunya is a disease caused by a virus of the same name. It was first identified following an outbreak in Tanzania in 1952. The name is derived from a word in the Tanzanian language Makonde, and means "that which bends up", owing to the joint pain it can cause. It is spread by mosquito bites, specifically from yellow fever and tiger mosquitoes, in tropical and subtropical regions. What are the symptoms? Typical symptoms include fever, muscle pain, nausea, fatigue and a rash. The UKHSA says joint pain can persist for months or even years, with up to 12% of people still experiencing discomfort three years after infection. The majority of people who become infected recover within one to two weeks without needing medical attention. Serious complications are uncommon, and only very rare cases are fatal. Babies or elderly people with other underlying illnesses are the most vulnerable. The two mosquitoes known to transmit the disease, yellow fever and tiger, are not currently found in the UK. How does oropouche virus differ? Oropouche virus is spread predominantly by midge bites rather than mosquito bites. While bites from both insects can cause red itchy lumps on the skin, mosquito bites are generally larger and more painful, while midge bites are smaller and may last longer. Symptoms can be similar to chikungunya, and include joint paint, headache, chills, nausea and high fever. The UKHSA says anyone who becomes unwell with these symptoms after travelling should seek "urgent medical advice". Where can you catch the viruses? Regular outbreaks of chikungunya occur in Africa, Asia and the Americas, with occasional smaller instances in Europe. The UKHSA said the majority of the 73 reported cases from the first six months of this year reported travelling to Sri Lanka, India and Mauritius. The cases were linked to local outbreaks in the Indian Ocean region. As of last month, there have been about 240,000 cases of chikungunya - and 90 deaths - in 16 countries, according to the European Centres for Disease Prevention and Control (ECDC). Meanwhile, all the UK cases of oropouche virus were associated with travel to Brazil. Last year, 44 cases were reported in several European countries including Spain, Italy, France, Germany, Austria, Sweden and the Netherlands, according to the ECDC. China is currently experiencing the biggest chikungunya outbreak ever documented in the country, according to Cesar Lopez-Camacho of the University of Oxford. More than 7,000 cases have been reported since June, with 90% of those concentrated in Guangdong province, which borders Hong Kong. How to prepare before travelling Dr Philip Veal, a consultant in public health at UKHSA said it is "essential" for people to take precautions against mosquito bites when travelling. "Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk," he said. Checking the latest health advice on your destination before you travel is also recommended. The LSHTM added that people can do the following to reduce exposure to mosquito and midge bites: • Fit screens to windows and doors; • Avoid peak activity during dusk and dawn; • Get rid of any standing water where mosquitoes breed. There are also two vaccines for chikungunya approved for use in the UK: IXCHIQ, for people aged 18 to 59 and Vimkunya, for individuals 12 years and older. Both are available to buy privately from travel clinics after an assessment by a healthcare professional. What's behind the increase in cases? The number of outbreaks of chikungunya has increased since 2000, Robert Jones, an assistant professor at the London School of Hygiene and Tropical Medicine (LSHTM) said. Mr Jones put this boom partly down to climate change and urban expansion. Dr Yang Liu, another professor at LSHTM, said the outbreak in China is not totally unexpected, but highlights the manifestation of a known risk, as yellow fever and tiger mosquitoes have been present in the area for many years.
Telegraph
22 minutes ago
- Telegraph
ADHD drug can reduce patients' criminal behaviour
Drug treatment for ADHD can reduce patients' substance misuse, suicidal behaviour and criminal behaviour, a new study has found. Symptoms of ADHD (attention deficit hyperactivity disorder) can involve being inattentive, hyperactive and impulsive. The neurodevelopmental disorder is thought to affect about 5 per cent of children and 2.5 per cent of adults worldwide, while almost 2.5 million people in England have ADHD, according to the first estimates by the NHS. The study, which appeared in the British Medical Journal, examined 148,581 people in Sweden who had a new diagnosis of ADHD. Drug treatment for the disorder was associated with reduced rates of suicidal behaviour, substance misuse, transport accidents and criminality. 'These results provide evidence on the effects of ADHD drug treatment on important health-related and social outcomes that should inform clinical practice and the debate on the drug treatment of ADHD,' the report said. In June, a taskforce said NHS waiting lists for ADHD diagnosis and support have led to a 'significant growth in the use of private providers that are not regulated'. The ADHD taskforce, commissioned by NHS England with the support of the Government, published an interim report saying the system for diagnosing and managing the disorder needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Wait times for NHS ADHD services 'have escalated and are unacceptably long' and demand is 'very likely' to continue to rise, the study warned. The NHS has launched publicly available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing.
